Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000212837 | SCV000171043 | benign | not specified | 2014-05-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000127470 | SCV000214796 | likely benign | Hereditary cancer-predisposing syndrome | 2014-07-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000199528 | SCV000253297 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001725992 | SCV000601846 | likely benign | not provided | 2023-06-15 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000127470 | SCV000686181 | likely benign | Hereditary cancer-predisposing syndrome | 2015-08-04 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000212837 | SCV000697347 | likely benign | not specified | 2019-08-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001725992 | SCV001962032 | likely benign | not provided | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000212837 | SCV002760387 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149867 | SCV003837741 | likely benign | Breast and/or ovarian cancer | 2022-08-15 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003952668 | SCV004773618 | likely benign | PMS2-related condition | 2020-02-11 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |